Clinical Trials Logo

Anaphylactic Reaction clinical trials

View clinical trials related to Anaphylactic Reaction.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06405399 Completed - Clinical trials for Anaphylactic Reaction

Design, Implementation and Evaluation of the Guided Observer Role in Clinical Simulation

Start date: May 10, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to assess the effectiveness of the guided observed role in a simulation learning programme for nursing students in acquiring the competence (knowledge, skills and attitudes) to care for patients affected by anaphylactic situations. This will be achieved by comparing the participants' simulation roles with the guided observed role. The design was that of an exploratory randomised controlled trial. The variables employed to assess the efficacy of the intervention were competence and its associated attributes. These were measured using a ten-question multiple-choice test to assess knowledge; the simulation performance assessment using the Creighton Simulation Evaluation Instrument to assess skill; the learner's perception of the simulation's effectiveness in meeting their learning needs, through the Simulation Effectiveness Tool Modified (SET-M). Furthermore, the extent to which reflective thinking was achieved during the simulation was evaluated using the Self-Debriefing Reflection Rubric. Additionally, the students' perceptions of their role were assessed through seven open-ended questions.

NCT ID: NCT06205134 Completed - Anaphylaxis Clinical Trials

Comparative Bioavailability of Intranasal Epinephrine

Start date: August 22, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

A Study to Compare the Bioavailability of Epinephrine following a Single Nasal Dose of FMXIN002 Microspheres Powder 3.6 mg, and 4mg with EpiPen 0.3mg Intramuscular Injection in Healthy Adults

NCT ID: NCT05152901 Completed - Clinical trials for Anaphylactic Reaction

Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults

Start date: January 6, 2022
Phase: Phase 1
Study type: Interventional

This is a study to determine the relative bioavailability of inhaled epinephrine compared with 0.3mg epinephrine administered IM in healthy male and female participants.